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Hello everyone.  My name is Heather Piwowar, and I’m from 
the University of Pittsburgh.  Today I’m going to be talking 
about sharing research data. 
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2PAST MEDICAL HISTORY:
Past medical history showed she had 
superficial phlebitis times two in the past, had 
non-insulin dependent diabetes mellitus for 
four years.
She had been hypothyroid for three years. 
HISTORY OF PRESENT ILLNESS:
The patient is a 58-year-old female, …
Sharing research data
http://upload.wikimedia.org/wikipedia/commons/7/76/PeptideMSMS.jpg; http://en.wikipedia.org/wiki/Image:Helices.png;  
http://en.wikipedia.org/wiki/Image:Heatmap.png; http://en.wikipedia.org/wiki/Image:Microarray2.gif; 
http://zellig.cpmc.columbia.edu/medlee/demo/; htp://www.plosone.org/article/fetchArticle.action?articleURI=info:doi/10.1371/journal.pone.0000441
Authors have a choice.  When scientists like us do research and we collect or 
compute individual data points – perhaps  3d protein coordinates, or de-identified 
hospital reports, or patient clinical trial covariates or protein spectra or gene 
expression microarray values – we have a choice.  We can make these detailed 
primary data points available when we publish our research, or we can keep them to 
ourselves. 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
07
.3
61
.1
 : 
Po
st
ed
 5
 J
ul
 2
00
7
3Shared data benefits science
• Verify
• Understand
• Extend
• Explore
• Combine
• Synergize
• Train
• Reduce
Whenever we choose to share, the whole scientific community benefits. Many of the 
opportunities fo reuising data are obvious, but let me recount a few since it isn’t 
something that most of us spend time thinking about.
Verify
Understand
Extend
Explore
Combine
Synergize
Train
Reduce resource use and fraud
So that is great.  But.
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4• Find
• Organize
• Document
• Deidentify
• Format
• Decide
• Ask
• Submit
• Answer questions
• Worry about mistakes being found
• Worry about data being misinterpreted
• Worry about being scooped
• Forgo money and IP and prestige???
But… costly for authors
Except for helping to fund and maintain some public databases,almost all of the COST of sharing 
data isn’t born by te whole community.  The costs are felt by the authors each time they share their 
data.  The steps I’m going to outline will feel very familiar to those of you who have made your 
data sets publicly available in the past.
Authors have to find their data, which in our busy and disorganized lives isn’t always as easy as it 
should be.  Then we have to format them, document, ….
Find
Organize
Document
Deidentify
Format
Decide
Ask  patients, IRBs,  funders, co-authors
Submit
Answer questions
Concurrently with this, we are maybe
Worry about mistakes being found
Worry about data being misinterpreted
Worry about being scooped
And potentially afraid 
Forgo money and intellctual property and prestige???
Not very motivating. 
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5So what’s in it for them?
Carrot.
A currency of value?
Citations.
$50!
Do trials which share their data 
receive more citations?
So what is in it for the authors?  What are some carrots we can offer, in addition to 
altruism?  There are sticks already – some funders including the NIH and some 
journals, particularly Nature and Science, make it mandatory to share some types of 
data.  But if we want to appeal to human nature and offer incentives, what can we 
do?
One idea is that Academics value citations.  Although they are imperfect as 
measures of scientific value , they are nonetheless used as a proxy for scientific 
contribution.  In fact, a study done in the 1980s looked at the correlation between 
promotions and academic salary increases.  They estimate that each citation 
indirectly led to a $50 raise. 
Believe that or not, but increasing citations has indeed been identified as a 
motivator for people to publish in open access journals, and we believe it may also 
encourage authors to make data available.  
Therefore, this study addresses the question:
Do trials which share their data receive more citations?
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6Methods
Cancer Microarray Trials
Ntzani and Ioannidis identified 85 trials published 1999-2003
Citations
ISI Web of Science Citation Index, citations from 2004-2005
Data availability
Publisher and lab websites, microarray databases, 
WayBack Internet Archive, Oncomine
Statistics
Multivariate linear regression
Briefly, to answer this question, we followed the citation history of 85 microarray
trials.  These publications included all of the studies which tried to associate 
microarray gene expression with cancer outcomes between 1999 and 2003.  We
scoured the internet for the datasets, and found the Oncomine database at the 
University of Michigan particularily helpful.  Finally, we used multivariate linear 
regression to investigate the relationship between data availablility and number of 
citations, independently of other factors which are known to affect citation rate.
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7Results:
Eligible trials
• 85 trials
• 41 (48%) made data available
• Various locations:
– Lab websites (28)
– Publisher websites (4)
– SMD (6)
– GEO (6)
– GEDP (2) 
• 6239 total citations
Here’s what we found.  Of the 85 trials, 41 made their data available.  Most datasets 
were found on lab websites, but some were also as supplementary info in journal 
websites or at the Stanford Microarray Database, The Gene Expression Omnibus…
you can see a link on Pubmed to GEO for the papers which have data in that 
database, or other centralized datastores.
There were over 6000 total citations. 
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8Results:  
Big picture
85 clinical trials used 
microarrays to study cancer 
between 1999-2003
These 85 trials were cited 
6239 times 
during 2004-2005
41 (48%) of these trials 
made their microarray 
data publicly available 
on the internet
Trials which shared 
data received 
5334 (85%) 
of these citations
Number of trials        Number of citations
And, indeed, the 48% of trials which made their data available received 85% of the 
total citations… clearly more than their fare share.
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9Results:  
Distribution of citation counts
From:  Piwowar HA, Day RS, Fridsma DB (2007) Sharing Detailed Research Data Is Associated with Increased Citation Rate. 
PLoS ONE 2(3): e308. doi:10.1371/journal.pone.0000308
A more detailed view can be seen on this diagram.  The publications which did not 
make their data available had a median of 20 citations, whereas on the right, the 
publications which did make their data available had a median of about 100 
citations.   The Y axis is a log scale, in case you can’t see that in the back.
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Results:  
Multivariate regression
From:  Piwowar HA, Day RS, Fridsma DB (2007) Sharing Detailed Research Data Is Associated with Increased Citation Rate. 
PLoS ONE 2(3): e308. doi:10.1371/journal.pone.0000308
Since it is possible that perhaps all of the publications which made their data 
available were also published in big-name journals and thus the higher number of 
citations is simply due to journal prestige rather than the data availability, we did a 
multivariate regression including journal impact as well as other factors.  The results 
were that making data available was associated with a 70% increase in the number 
of citations, independently of other covariates.
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Limitations
• Outliers
– Subset analysis of lower profile papers
• Complex timing
– Additional analysis of citations within 24 months
• Association does not imply causation
– Could be common cause
It is of course necessary to mention some of the limitations of this study.  Our cohort 
included the Golub dataset.  Has anybody heard of that?  Yup.  It is famous.  They
made their data available, and many people use it.  They were the first ones to use 
microarrays with clinical cancer outcomes, and as such they have received a
phenominial amount of citations, many more than normal papers do.  Because of 
this and other outliers in our sample, we did perform a subset analysis on the lower-
profile papers and our results were similar to those I’ve shown.
A second limitation comes from complex timing.  The microarray field has been 
growing and maturing over the last 8 years.  A paper published today receives many 
more citations than one published in 1999 simply because more scientists are 
working in this area.  At the same time, any given paper has its own natural citation 
trajectory in time:  it takes a few months before it receives any citations, and after a 
few years its citations begin to dwindle again.  Our primary analysis looked at 
citations in 2004 and 2005, but because of this complex timing, we also had a look 
at citations within 24 months of each paper publication.  Again, the results were 
similar.
Finally and most importantly, as we all know, association does not imply causation.  
An association may instead be due, for example, to a common cause.  It is possible 
that large, well-funded, clinically relevant trials are more apt to share their data 
because they are relatively well funded, however their large number of citations 
have nothing to do with data availability but are rather because the trial addresses 
an important issue.  Nonetheless, we speculate that a number of the citations are 
indeed caused by the data sharing, but that hasn’t been shown as part of this study.
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Data sharing help on the way
• Free, centralized databases
– SMD, GEO, ArrayExpress
• Standards
– MIAME, CONSORT
• Tools
– De-id, caBIG
• Community
– Journals, Funders, Organizations, Blogs
In the interest of time, I’ll let you read for yourselves about tools and initiatives 
underway to make data sharing easier for authors.
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Conclusions
• 70% increase in citation impact for trials 
which make data available
• Result holds for lower-profile publications
• Hopefully a motivation for authors to share 
data and thus maximize its usefulness 
So, in conclusion, we have found that sharing raw research datapoints is associated 
with about a 70% increase in citations, a currency of value to authors.  This is the 
first study to demonstrate such an association, and we hope it will provide a 
motivation for researchers to share data with one another. 
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For more information
• Participate in the discussion on this paper
at PLoS ONE
• Check out blogs on Open Access, Open Data, 
Open Notebook Science
– Peter Suber’s Open Access News blog
– Wikipedia:  “Open Data”
– Nature Editorial:  May 3, 2007
• Contact Heather Piwowar for further discussion 
and enthusiasm!      hpiwowar@alumni.pitt.edu
If you would like more information on this topic, please have a look at our published 
paper at PLoS ONE (which is a great open access journal, by the way), participate 
in the ongoing dialog about open data and open science, and please contact me.
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Thank you
• Peter Suber’s blog:  “Open Access News”
• Wikipedia:  “Open Data”
• Nature Editorial:  May 3, 2007
I support Open Data 
and share my literature, code, and data whenever possible.  
Long term research interest:  
data reuse as an underutilized informatics resource
Questions?
I do appreciate your attention during this last session of our conference.  I’d like to 
thank the NLM for its generous funding, and also thanks to each and every one of 
you who have made your detailed research data available in the past, or will do so 
in the future.
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
do
i:1
0.
10
38
/n
pr
e.
20
07
.3
61
.1
 : 
Po
st
ed
 5
 J
ul
 2
00
7
